Clinicopathological, genomic and immunological factors in colorectal cancer prognosis

ConclusionCurrent strategies for managing CRC are strongly dependent on clinicopathological staging, although molecular testing is increasingly being implemented into routine clinical practice. As immunological biomarkers are further validated, their testing may also become routine. To obtain clinically useful information from new biomarkers, it is important to implement them into a model that includes all underlying fundamental factors, as this will enable the best possible outcomes and deliver true precision medicine.
Source: British Journal of Surgery - Category: Surgery Authors: Tags: Review Source Type: research